Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPT-11 in Advanced Gastric/GEJ Adenocarcinoma
NCT00003137Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 1997
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of irinotecan in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Cancer and Leukemia Group B. Started Dec 1997; status: completed.
02
Drugs
irinotecan
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00003137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003137.